Election of Director to serve until Tevas 2027 Annual Meeting: Chen Lichtenstein
Election of Director to serve until Tevas 2028 Annual Meeting: Amir Elstein
Election of Director to serve until Tevas 2028 Annual Meeting: Roberto A. Mignone
Election of Director to serve until Tevas 2028 Annual Meeting: Dr. Perry D. Nisen
Election of Director to serve until Tevas 2028 Annual Meeting: Dr. Tal Zaks
To approve, on a non-binding advisory basis, the compensation for Tevas named executive officers
To approve an amended compensation policy with respect to the terms of office and employment of Tevas executive officers and directors
To approve an amendment to the terms of office and employment of Tevas president and chief executive officer
To approve the compensation to be provided to Tevas non- employee directors
To approve the compensation to be provided to Tevas non- executive chairman of the board
To appoint, Kesselman & Kesselman, a member of PriceWaterhouseCoopers International Ltd., as Tevas independent registered public accounting firm until Tevas 2026 annual meeting of shareholders.